Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Basal insulin therapy is associated with beneficial effects on postoperative infective complications, independently from circulating glucose levels in patients admitted for cardiac surgery.

Piatti PM, Cioni M, Magistro A, Villa V, Crippa VG, Galluccio E, Fontana B, Spadoni S, Bosi E, Monti LD, Alfieri O.

J Clin Transl Endocrinol. 2017 Feb 11;7:47-53. doi: 10.1016/j.jcte.2017.01.005. eCollection 2017 Mar.

2.

Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study).

Monti LD, Galluccio E, Villa V, Fontana B, Spadoni S, Piatti PM.

Eur J Nutr. 2017 Oct 20. doi: 10.1007/s00394-017-1548-2. [Epub ahead of print]

PMID:
29052766
3.

Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial.

Monti LD, Galluccio E, Fontana B, Spadoni S, Comola M, Marrocco Trischitta MM, Chiesa R, Comi G, Bosi E, Piatti P.

Metabolism. 2015 Nov;64(11):1582-91. doi: 10.1016/j.metabol.2015.08.015. Epub 2015 Aug 28.

PMID:
26385052
4.

Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome.

Piatti P, Setola E, Galluccio E, Costa S, Fontana B, Stuccillo M, Crippa V, Cappelletti A, Margonato A, Bosi E, Monti LD.

Acta Diabetol. 2014 Oct;51(5):793-9. doi: 10.1007/s00592-014-0599-6. Epub 2014 Jun 17.

PMID:
24934227
5.

A novel truncated form of eNOS associates with altered vascular function.

Galluccio E, Cassina L, Russo I, Gelmini F, Setola E, Rampoldi L, Citterio L, Rossodivita A, Kamami M, Colombo A, Alfieri O, Carini M, Bosi E, Trovati M, Piatti P, Monti LD, Casari G.

Cardiovasc Res. 2014 Mar 1;101(3):492-502. doi: 10.1093/cvr/cvt267. Epub 2013 Dec 3.

PMID:
24302629
6.

Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.

Baldi S, Bonnet F, Laville M, Morgantini C, Monti L, Hojlund K, Ferrannini E, Natali A; RISC Investigators.

Diabetes Care. 2013 Dec;36(12):4125-31. doi: 10.2337/dc13-0682. Epub 2013 Oct 15.

7.

Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study.

Kozakova M, Natali A, Dekker J, Beck-Nielsen H, Laakso M, Nilsson P, Balkau B, Ferrannini E; RISC Investigators.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1409-17. doi: 10.1161/ATVBAHA.112.300948. Epub 2013 Apr 18.

8.

L-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome.

Monti LD, Casiraghi MC, Setola E, Galluccio E, Pagani MA, Quaglia L, Bosi E, Piatti P.

Metabolism. 2013 Feb;62(2):255-64. doi: 10.1016/j.metabol.2012.08.004. Epub 2012 Oct 3.

PMID:
23040413
9.

Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial.

Piatti PM, Marone E, Mantero M, Setola E, Galluccio E, Lucotti P, Shehaj E, Villa V, Perticone F, Venturini M, Palini A, Airoldi F, Faglia E, Del Maschio A, Colombo A, Chiesa R, Bosi E, Monti LD.

Acta Diabetol. 2013 Jun;50(3):373-82. doi: 10.1007/s00592-012-0426-x. Epub 2012 Aug 21.

PMID:
22907764
10.

Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial.

Monti LD, Setola E, Lucotti PC, Marrocco-Trischitta MM, Comola M, Galluccio E, Poggi A, Mammì S, Catapano AL, Comi G, Chiesa R, Bosi E, Piatti PM.

Diabetes Obes Metab. 2012 Oct;14(10):893-900. doi: 10.1111/j.1463-1326.2012.01615.x. Epub 2012 May 21.

PMID:
22553931
11.

From metabolic normality to cardiometabolic risk factors in subjects with obesity.

Bobbioni-Harsch E, Pataky Z, Makoundou V, Laville M, Disse E, Anderwald C, Konrad T, Golay A; RISC Investigators.

Obesity (Silver Spring). 2012 Oct;20(10):2063-9. doi: 10.1038/oby.2012.69. Epub 2012 Mar 16.

12.

Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.

Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, Gastaldelli A, Ferrannini E; RISC Investigators.

Hepatology. 2012 May;55(5):1406-15. doi: 10.1002/hep.25555.

PMID:
22334565
13.

Aerobic and resistance training effects compared to aerobic training alone in obese type 2 diabetic patients on diet treatment.

Lucotti P, Monti LD, Setola E, Galluccio E, Gatti R, Bosi E, Piatti P.

Diabetes Res Clin Pract. 2011 Dec;94(3):395-403. doi: 10.1016/j.diabres.2011.08.002. Epub 2011 Sep 3.

PMID:
21890226
14.

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.

Handberg A, Højlund K, Gastaldelli A, Flyvbjerg A, Dekker JM, Petrie J, Piatti P, Beck-Nielsen H; RISC Investigators.

J Intern Med. 2012 Mar;271(3):294-304. doi: 10.1111/j.1365-2796.2011.02442.x. Epub 2011 Sep 14.

15.

Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study.

Rebelos E, Muscelli E, Natali A, Balkau B, Mingrone G, Piatti P, Konrad T, Mari A, Ferrannini E; RISC Study Investigators.

Diabetes. 2011 Jul;60(7):1938-45. doi: 10.2337/db11-0217. Epub 2011 May 26.

16.

Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women.

Bonnet F, Ducluzeau PH, Gastaldelli A, Laville M, Anderwald CH, Konrad T, Mari A, Balkau B; RISC Study Group.

Diabetes. 2011 Jun;60(6):1660-7. doi: 10.2337/db10-1806. Epub 2011 Apr 26.

17.

Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study.

Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, Laakso M, Beck-Nielsen H, Mari A; RISC Investigators.

Diabetologia. 2011 Jun;54(6):1507-16. doi: 10.1007/s00125-011-2112-x. Epub 2011 Mar 22.

PMID:
21424899
18.

A novel surrogate index for hepatic insulin resistance.

Vangipurapu J, Stančáková A, Kuulasmaa T, Paananen J, Kuusisto J; EGIR-RISC Study Group, Ferrannini E, Laakso M.

Diabetologia. 2011 Mar;54(3):540-3. doi: 10.1007/s00125-010-1966-7. Epub 2010 Nov 25.

PMID:
21107521
19.

Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease.

Monti LD, Lucotti PC, Setola E, Rossodivita A, Pala MG, Galluccio E, LaCanna G, Castiglioni A, Cannoletta M, Meloni C, Zavaroni I, Bosi E, Alfieri O, Piatti PM.

Nutr Metab Cardiovasc Dis. 2012 Jan;22(1):58-65. doi: 10.1016/j.numecd.2010.04.005. Epub 2010 Aug 14.

PMID:
20709514
20.

Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance.

Natali A, Muscelli E, Mari A, Balkau B, Walker M, Tura A, Anderwald C, Golay A, Ferrannini E; Relationship between Insulin Sensitivity and Cardiovascular disease investigators.

J Clin Endocrinol Metab. 2010 Oct;95(10):4703-11. doi: 10.1210/jc.2009-2721. Epub 2010 Jul 21.

PMID:
20660046

Supplemental Content

Loading ...
Support Center